Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.42 |
| ▸ | KDM5A | P29375 | 3/20 | 0.42 |
| ▸ | KDM4A | O75164 | 5/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 5/20 | 0.41 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1671482 | 0.98 | MEN1 (0.61) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| SCHEMBL10084980 | 0.93 | TSHR (0.61) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| SCHEMBL18556504 | 0.91 | TSHR (0.58) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| SCHEMBL711981 | 0.91 | TSHR (0.58) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| SCHEMBL25181649 | 0.90 | TSHR (0.52) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| SCHEMBL14430424 | 0.86 | MEN1 (0.71) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| SCHEMBL215293 | 0.85 | — | — | |
| SCHEMBL31647713 | 0.83 | DNM1 (0.47) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL12488733 | 0.83 | KMT2A (0.74) | TSHRMEN1KMT2ADNM1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL4390740 | 0.83 | KMT2A (0.74) | TSHRMEN1KMT2ADNM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098635-A1 | NEW CATIONIC LIPID WITH NITROGEN-CONTAINING HETEROCYCLIC HEAD GROUP AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-118955655-A | GE protein antigen variant, preparation method and application thereof | 北京微星生物科技有限公司 | 2024-11-15 | — | — | CN | claimed |
| WO-2024078534-A1 | INTERFERING RNA FOR INHIBITING EXPRESSION OF MELANOPHILIN (MLPH) GENE, AND APPLICATION THEREOF | 北京键凯科技股份有限公司 | 2024-04-18 | — | — | WO | claimed |
| CN-116322788-A | Cyclic RNA compositions and methods | 奥纳治疗公司 | 2023-06-23 | — | — | CN | claimed |
| WO-2023081494-A2 | NUCLEOSIDE MODIFIED MRNA AND USES THEREOF | BOSTON MEDICAL CENTER CORPORATION (US) | 2023-05-11 | — | — | WO | claimed |
| CN-115803049-A | Antigen encoding cassette | 磨石生物公司 | 2023-03-14 | — | — | CN | claimed |
| CN-113151312-B | Novel coronavirus SARS-CoV-2mRNA vaccine and its preparation method and application | 中国科学院微生物研究所 | 2022-12-09 | — | — | CN | claimed |
| CN-114272369-A | mRNA vaccine composition for preventing varicella-zoster virus | 中国科学院微生物研究所 | 2022-04-05 | — | — | CN | claimed |
| EP-3364950-A1 | TROPICAL DISEASE VACCINES | ModernaTX, Inc. (US) | 2018-08-29 | — | — | EP | claimed |
| EP-3364949-A1 | CANCER VACCINES | ModernaTX, Inc. (US) | 2018-08-29 | — | — | EP | claimed |
| US-9278907-B2 | Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease | JSC GRINDEKS (LV) | 2016-03-08 | — | — | US | claimed |
| US-8940793-B2 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | JSC GRINDEKS (LV) | 2015-01-27 | — | — | US | claimed |
| EP-2491005-B1 | USE OF 4-[ETHYL(DIMETHYL)AMMONIO]BUTANOATE IN THE TREATMENT OF CARDIOVASCULAR DISEASE | GRINDEKS JSC (LV) | 2014-07-23 | — | — | EP | claimed |
| US-20140107202-A1 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | JSC GRINDEKS (LV) | 2014-04-17 | — | — | US | claimed |
| EP-2702037-A1 | 4-[(HALOALKYL)(DIMETHYL)AMMONIO]BUTANOATES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASE | Grindeks, A Joint Stock Company (LV) | 2014-03-05 | — | — | EP | claimed |
| WO-2012146737-A1 | 4-[(HALOALKYL)(DIMETHYL)AMMONIO]BUTANOATES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASE | GRINDEKS, A JOINT STOCK COMPANY (LV) | 2012-11-01 | — | — | WO | claimed |
| US-20120220656-A1 | USE OF 4-[ETHYL(DIMETHYL)AMMONIO]BUTANOATE IN THE TREATMENT OF CARDIOVASCULAR DISEASE | JSC GRINDEKS (LV) | 2012-08-30 | — | — | US | claimed |
| EP-2491005-A1 | USE OF 4-[ETHYL(DIMETHYL)AMMONIO]BUTANOATE IN THE TREATMENT OF CARDIOVASCULAR DISEASE | Grindeks, A Joint Stock Company (LV) | 2012-08-29 | — | — | EP | claimed |
| WO-2011048201-A1 | USE OF 4-[ETHYL(DIMETHYL)AMMONIO]BUTANOATE IN THE TREATMENT OF CARDIOVASCULAR DISEASE | GRINDEKS, A JOINT STOCK COMPANY (LV) | 2011-04-28 | — | — | WO | claimed |
| CN-1289249-A | Derivatives of 1,3,4-oxadiazolone | BRISTOL MYERS SQUIBB CO (US) | 2001-03-28 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107202-A1 | 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease | FABP3, HCN3, HCN4 | TSHR 2698/4885MEN1 3768/4885KMT2A 1305/4885 |
| US-20120220656-A1 | USE OF 4-[ETHYL(DIMETHYL)AMMONIO]BUTANOATE IN THE TREATMENT OF CARDIOVASCULAR DISEASE | FABP3, ABAT, BBOX1 | TSHR 4548/4885MEN1 3008/4885KMT2A 1575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.